Skip to main content
SpringerLink
Log in

Effects of Antihypertensive Drugs on Endocrine Function

  • Review Articles
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Pharmacological treatment of hypertension can cause clinically significant alterations in endocrine function through effects on glucose homeostasis, thyroid and parathyroid hormones, adrenal steroid metabolism and reproductive/pituitary physiology. Long term use of thiazide diuretics causes deterioration in glucose tolerance, probably secondary to potassium depletion. Hypoglycaemic complications of β-blockers (mainly the non-selective compounds) can be dramatic, especially in type I diabetics. Clonidine, diazoxide and calcium antagonists have all been associated with deterioration in glucose tolerance and their long term use should be avoided in type II diabetics if possible.

Propranolol lowers T3 levels by decreasing the conversion of T4 to T3. Prazosin causes elevations in T4 and thyroid-stimulating hormone, while sodium nitroprusside use may result in hypothyroidism. Numerous agents are associated with sexual dysfunction, including methyldopa, reserpine, clonidine and spironolactone. Thiazide diuretics may cause hypercalcaemia, particularly in patients with hyperparathyroidism, by decreasing urinary calcium as well as directly influencing bone and gut calcium handling. Conversely, propranolol may decrease circulating parathyroid hormone levels and correct the hypercalcaemia seen in hyperparathyroidism.

Awareness of drug-induced changes in endocrine function will facilitate the rational management of the hypertensive patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adams, P.; Chalmers, T.M.; Hill, L.F. and Truscott, B.: Idiopathic hypercalcaemia and hyperparathyroidism. British Medical Journal 4: 582–585 (1970).

    PubMed  CAS  Google Scholar 

  • Ahmad, S.: Hydralazine and male impotence. Chest 78: 758 (1980).

    Google Scholar 

  • Amery, A.; Berthaux, P.; Bulpitt, C.; Deruyttere, M; De-Schaepdryver, A.; Dollery, C.; Fagard, R.; Forette, F.; Hellemans, J.; Lund-Johansen, P.; Mutsers, A. and Tuomilehto, J.: Glucose intolerance during diuretic therapy. Lancet 1: 681–683 (1978).

    PubMed  CAS  Google Scholar 

  • Arze, R.S.; Ramos, J.M.; Rashid, H.V. and Kerr, J.N.S.: Amenorrhoea, galactorrhoea and hyperprolactinaemia induced by methyldopa. British Medical Journal 283: 194 (1981).

    PubMed  CAS  Google Scholar 

  • Avery, G.S. (Ed.): Diazoxide: A review of its pharmacological properties and therapeutic use in hypertensive crises. Drugs 2: 78–137 (1971).

    Google Scholar 

  • Barzune, L.S. and Settser, H.S.: Impingement of various diabetogenic agents upon beta cell responsiveness. Clinical Research 16: 32 (1968).

    Google Scholar 

  • Bax, N.D.S.; Lennard, M.S. and Tucker, G.T.: Effect of beta-blockers on thyroid hormones. British Medical Journal 281: 1283 (1980).

    PubMed  CAS  Google Scholar 

  • Beardwood, D.M.; Alder, J.S.; Graham, C.A.; Beardwood, J.T. and Marble, A.: Evidence for a peripheral action of chlorothiazide in normal man. Metabolism 14: 561–567 (1965).

    PubMed  CAS  Google Scholar 

  • Bengtsson, C.: Impairment of glucose metabolism during treatment with antihypertensive drugs. Acta Medica Scandinavica Suppl. 628: 63–70 (1978).

    Google Scholar 

  • Bengtsson, C.; Blohme, G. and Waidenstrom, J.: Diabetes mellitus, carbohydrate tolerance and early insulin response to an intravenous glucose injection in a population sample of women and in women with ischaemic heart disease. Acta Medica Scandinavica 549 (Suppl.): 65–74 (1973).

    Google Scholar 

  • Berglund, G. and Andersson, O.: Beta blockers or diuretics in hypertension. A six year follow-up of blood pressure and metabolic side effects. Lancet 1: 744–747 (1981).

    PubMed  CAS  Google Scholar 

  • Bohnet, H.G.; Dahlen, H.G.; Wuttke, W. and Schneider, H.P.G.: Hyperprolactinemic anovulatory syndrome. Journal of Clinical and Endocrinological Metabolism 42: 132–143 (1976).

    CAS  Google Scholar 

  • Boyden, T.W.; Nugent, C.A.; Ogihara, T. and Maeda, T.: Reserpine, hydrochlorothiazide and pituitary-gonadal hormones in hypertensive patients. European Journal of Clinical Pharmacology 17: 329–332 (1980).

    PubMed  CAS  Google Scholar 

  • Brickman, A.S.; Massry, S.G. and Coburn, J.W.: Changes in serum and urinary calcium during treatment with hydrochlorothiazide: Studies on mechanisms. Journal of Clinical Investigation 51: 945–954 (1972).

    PubMed  CAS  Google Scholar 

  • Bulpitt, C.J. and Dollery, C.T.: Side effects of hypotensive agents evaluated by a self-administered questionnaire. British Medical Journal 3: 485–490 (1973).

    PubMed  CAS  Google Scholar 

  • Buse, M.G.; Johnson, A.H.; Kupermine, D. and Buse, J.: Effect of α-adrenergic blockade on insulin secretion in man. Metabolism 19: 219–225 (1970).

    PubMed  CAS  Google Scholar 

  • Carlson, H.E.: Gynecomastia. New England Journal of Medicine 303: 795–799 (1980).

    PubMed  CAS  Google Scholar 

  • Caro, J.F.; Bejarab, A.; Burke, J.F. and Glennon, J.A.: A possible role for propranolol in the treatment of renal osteodystrophy. Lancet 2: 451–453 (1978).

    PubMed  CAS  Google Scholar 

  • Caro, J.F. and Besarab, A.: Propranolol therapy for hyperparathyroidism. Lancet 1: 827 (1978).

    PubMed  CAS  Google Scholar 

  • Caro, J.F.; Castro, J.H. and Glennon, J.A.: Effect of long term propranolol administration on parathyroid hormone and calcium concentration in primary hyperparathyroidism. Annals of Internal Medicine 91: 740–741 (1979).

    PubMed  CAS  Google Scholar 

  • Cavalierei, R.R. and Pitt-Rivers, R.: The effects of drugs on the distribution and metabolism of thyroid hormones. Pharmacological Reviews 33: 55–80 (1981).

    Google Scholar 

  • Cerasi, E.; Luft, R. and Efendic, S.: Effect of adrenergic blocking agents on insulin response to glucose infusion in man. Acta Endocrinologica 69: 335–346 (1972).

    PubMed  CAS  Google Scholar 

  • Charles, M.A. and Danforth, E.: Nonketoacidotic hyperglycemia and coma during intravenous diazoxide therapy in uremia. Diabetes 20: 501–503 (1971).

    PubMed  CAS  Google Scholar 

  • Cheng, S.C.; Suzuki, K.; Sadee, W. and Harding, B.W.: Effects of spironolactone, canrenone and canrenoate-K on cytochrome P-450, and 11-β and 18-hydroxylation in bovine and human adrenal cortical mitochondria. Endocrinology 99: 1097–1106 (1976).

    PubMed  CAS  Google Scholar 

  • Coevoet, B.; Desplan, C.; Sebert, J.L.; Makdassi, R.; Andrejak, M.; Gheerbrant, J.M.; Tolani, M.; Calmette, C.; Moukhtar, M.S. and Fournier, A.: Effect of propranolol and metoprolol on parathyroid hormone and calcitonin secretions in uraemic patients. British Medical Journal 280: 1344–1346 (1980).

    PubMed  CAS  Google Scholar 

  • Conn, J.W.: Hypertension, the potassium ion and impaired carbohydrate tolerance. New England Journal of Medicine 273: 1135–1143 (1965).

    PubMed  CAS  Google Scholar 

  • Coppula, J.A.; Leonardi, R.G. and Lippman, W.: Ovulatory failure in rats after treatment with brain norepinephrine depletors. Endocrinology 78: 225–228 (1966).

    Google Scholar 

  • Cruickshank, J.M.: The clinical importance of cardioselectivity and lipophilicity in beta blockers. American Heart Journal 100: 160–178 (1980).

    PubMed  CAS  Google Scholar 

  • Cryer, P.E.: Glucose counterregulation in man. Diabetes 30: 261–264 (1981).

    PubMed  CAS  Google Scholar 

  • Davis, G.; Somers, G.; Van Obberghen, E. and Malaisse, W.J.: Calcium antagonists and islet function, I. Inhibition of insulin release by verapamil. Diabetes 24: 547–551 (1975).

    Google Scholar 

  • Day, J.L.; Simpson, N.; Metcalfe, J. and Page, R.L.: Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. British Medical Journal 1: 77–80 (1979).

    PubMed  CAS  Google Scholar 

  • Deacon, S.P.; Karunanayake, H. and Barnett, D.: Acebutolol, atenolol and propranolol and metabolic responses to acute hypoglycaemia in diabetics. British Medical Journal 2: 1255–1257 (1977).

    PubMed  CAS  Google Scholar 

  • Eto, S.; McMillen-Wood, J.; Hutchins, M. and Fleischer, N.: Pituitary 45Ca uptake and release of ACTH, GH and TSH: Effect of verapamil. American Journal of Physiology 226: 1315–1320 (1974).

    PubMed  CAS  Google Scholar 

  • Faber, J.; Friis, T.; Kirkegaard, C.; Lumholtz, L.B.; Hansen, J.M.; Siersbaek-Nielsen, K.; Skovsted, L. and Theilade, P.: Serum T4, T3 and reverse T3 during treatment with propranolol in hyperthyroidism, L-T4 treated myxedema and in normal man. Hormone and Metabolic Research 11: 34–36 (1979).

    PubMed  CAS  Google Scholar 

  • Feller, J.M.: Danger of hypoglycaemia with use of propranolol. Medical Journal of Australia 2: 92 (1973).

    PubMed  CAS  Google Scholar 

  • Franks, S.; Jacobs, H.S.; Martin, N. and Nabarro, J.D.N.: Hyperprolactinemia and impotence. Clinical Endocrinology 8(4): 277–287 (1978).

    PubMed  CAS  Google Scholar 

  • Friesen, H. and Hwang, P.: Human prolactin. Annual Review of Medicine 24: 251–270 (1973).

    PubMed  CAS  Google Scholar 

  • Garbus, S.B.; Weber, M.A.; Priest, R.T.; Brewer, D.D. and Hubbell, F.A.: The abrupt discontinuation of antihypertensive treatment. Journal of Clinical Pharmacology 19: 476–486 (1979).

    PubMed  CAS  Google Scholar 

  • Gerich, J.; Davis, J.; Lorenzi, M.; Rizza, R.; Bohannon, N.; Karam, J.; Lewis, S.; Kaplan, R.; Schultz, T. and Cryer, P.: Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. American Journal of Physiology 236: E380–E385 (1979).

    PubMed  CAS  Google Scholar 

  • Gibb, W.E.; Turner, P.; Malpas, J.S. and White, R.J.: Comparison of bethanadine, α-methyldopa and reserpine in essential hypertension. Lancet 2: 275–277 (1970).

    PubMed  CAS  Google Scholar 

  • Giugliano, D.; Torella, R.; Caciapuoti, F.; Gentile, S.; Verza, M. and Varricchio, M.: Impairment of insulin secretion in man by nifedipine. European Journal of Clinical Pharmacology 18: 395–398 (1980).

    PubMed  CAS  Google Scholar 

  • Gluskin, L.E.; Strasberg, B. and Shah, J.H.: Verapamil-induced hyperprolactinemia and galactorrhea. Annals of Internal Medicine 95: 66–67 (1981).

    PubMed  CAS  Google Scholar 

  • Goodner, C.J.; Koerker, C.J.; Werback, J.H.; Toirula, P. and Gale, C.C.: Adrenergic regulation of lipolysis and insulin secretion in the fasted baboon. American Journal of Physiology 224: 534–539 (1973).

    PubMed  CAS  Google Scholar 

  • Greenblatt, D.J. and Koch-Weser, J.: Gynecomastia and impotence: Complications of spironolactone therapy. Journal of the American Medical Association 223: 82 (1973).

    PubMed  CAS  Google Scholar 

  • Group, L. and Tutterman, K.J.: Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with noninsulin dependent diabetes mellitus. Acta Endocrinologica 100: 410–415 (1982).

    Google Scholar 

  • Hansson, L.; Hunyor, S.N.; Julius, S. and Hoobler, S.W.: Blood pressure crises following withdrawal of clonidine (Catapres, Catapresan) with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. American Heart Journal 85: 605–610 (1973).

    PubMed  CAS  Google Scholar 

  • Harms, H.H.; Gouren, L.; Spoelstra, A.J.G.; Hesse, C. and Verscheer, L.: Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol. British Journal of Clinical Pharmacology 5: 19–26 (1978).

    PubMed  CAS  Google Scholar 

  • Helderman, J.H.; Elahi, D.; Andersen, D.K.; Raizes, G.S.; Tobin, J.D.; Shocken, D. and Andres, R.: Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32: 106–111 (1983).

    PubMed  CAS  Google Scholar 

  • Hermansen, K. and Iversen, J.: Effect of verapamil on pancreatic glucagon release from the isolated, perfused canine pancreas. Scandinavian Journal of Clinical and Laboratory Investigation 37: 139–142 (1977).

    PubMed  CAS  Google Scholar 

  • Heyma, P.; Larkins, R.G.; Higgenbotham, L. and Ng, K.W.: D-propranolol and dl-propranolol both decrease conversion of 1-thyroxine to 1-triiodothyroxine. British Medical Journal 281: 24–26 (1980).

    PubMed  CAS  Google Scholar 

  • Hicks, B.H.; Ward, J.D.; Jarrett, R.J.; Keen, H. and Wise, P.: A controlled study of clopamide, clorexolone and hydrochlorothiazide in diabetics. Metabolism 22: 101–109 (1973).

    PubMed  CAS  Google Scholar 

  • Higgins, B.A.; Nassim, J.R.; Collins, J. and Holb, A.: The effect of bendrofluazide on urine calcium excretion. Clinical Science 27: 457–462 (1964).

    PubMed  CAS  Google Scholar 

  • Horowitz, J.D. and Goble, A.S.: Drugs and impaired male sexual function. Drugs 18: 206–217 (1979).

    PubMed  CAS  Google Scholar 

  • Huffman, D.H.; Kampmann, J.P.; Hignite, C.E. and Azarnoff, D.L.: Gynecomastia induced in normal males by spironolactone. Clinical Pharmacology and Therapeutics 24: 465–473 (1978).

    PubMed  CAS  Google Scholar 

  • Kallen, R.J.; Muhler, J.H. and Lin, H.L.: Hypoglycemia: A complication of treatment of hypertension with propranolol. Clinical Pediatrics 19: 567–568 (1980).

    PubMed  CAS  Google Scholar 

  • Khan, A.; Camel, G. and Perry, H.M.J.: Clonidine (Catapres): A new antihypertensive agent. Current Therapeutic Research 12: 10–18 (1970).

    PubMed  CAS  Google Scholar 

  • Khari, J.W.: Impotence from propranolol. Annals of Internal Medicine 85: 258 (1976).

    Google Scholar 

  • Klimiuk, P.S.; Davies, M. and Adams, P.H.: Primary hyperthyroidism and thiazide diuretics. Postgraduate Medical Journal 57: 80–83 (1981).

    PubMed  CAS  Google Scholar 

  • Kristensen, B.O.; Steiness, E. and Weeke, J.: Propranolol withdrawal and thyroid hormones in patients with essential hypertension. Clinical Pharmacology and Therapeutics 23: 624–629 (1978).

    PubMed  CAS  Google Scholar 

  • Kristensen, B.O. and Weeke, J.: Propranolol-induced increments in total and free serum thyroxine in patients with essential hypertension. Clinical Pharmacology and Therapeutics 22: 864–867 (1977).

    PubMed  CAS  Google Scholar 

  • Kukreja, S.C; Hargis, G.K.; Bowser, E.N.; Henderson, W.J.; Fisherman, E.W. and William, G.A.: Role of adrenergic stimuli in parathyroid hormone secretion in man. Journal of Clinical Endocrinology 40: 478–481 (1975).

    CAS  Google Scholar 

  • Lager, I.; Bluhme, G. and Smith, U.: Effect of cardioselective and non-selective β-blockade on the hypoglycaemic responses in insulin-dependent diabetes. Lancet 1: 458–462 (1979).

    PubMed  CAS  Google Scholar 

  • Lal, S.; Tolis, G.; Martin, J.B.; Brown, G.M. and Guyder, H.: Effect of clonidine on growth hormone, prolactin, luteinizing hormones, follicle-stimulating hormone and thyroid-stimulating hormone in the serum of normal man. Journal of Clinical Endocrinology and Metabolism 41: 827–836 (1975).

    PubMed  CAS  Google Scholar 

  • Lawson, A.A.H.: Potassium replacement: When is it necessary? Drugs 21: 354–361 (1981).

    PubMed  CAS  Google Scholar 

  • Leading Article: Drug-induced diabetes. Lancet 1: 328–329 (1965).

    Google Scholar 

  • Lee, P.A.; Kelly, M.R. and Wallin, J.D.: Increased prolactin levels during reserpine treatment in hypertensive patients. Journal of the American Medical Association 235: 2316–2317 (1976).

    PubMed  CAS  Google Scholar 

  • Lewis, P.J.; Petrie, A.; Kohner, E.M. and Dollery, C.T.: Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment. Lancet 2: 564–566 (1976).

    Google Scholar 

  • Ljunghall, S.; Rudberg, C.; Åkerstrom, G. and Wide, L.: Effects of beta-adrenergic blockade on serum parathyroid hormone in normal subjects and patients with primary hyperparathyroidism. Acta Medica Scandinavica 211: 27–30 (1981).

    Google Scholar 

  • Lloyd-Mostyn, R.H. and Oram, S.: Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet 1: 1213–1215 (1975).

    PubMed  CAS  Google Scholar 

  • Lockwood, C.H.; Nichollo, D.M.; Troop, V.L. and Lewis, J.A.: Diazoxide therapy in hypertension. American Journal of the Medical Sciences 246: 312–318 (1963).

    PubMed  CAS  Google Scholar 

  • Loubataires, A.; Mariani, M.M. and Alric, R.: The action of diazoxide on insulin secretion, medulla-adrenal secretion and the liberation of catecholamines. Annals of the New York Academy of Science 150: 226–239 (1968).

    Google Scholar 

  • Malluche, H.H.; Meyer-Sabellek, W.; Singer, F.R. and Massry, S.G.: Evidence for a direct effect of thiazides on bone. Mineral and Electrolyte Metabolism 4: 89–96 (1980).

    CAS  Google Scholar 

  • Massara, F.; Strumia, E.; Camanni, F. and Molinatti, G.M.: Depressed tolbutamide-induced response in subjects treated with propranolol. Diabetologia 7: 287–289 (1971).

    PubMed  CAS  Google Scholar 

  • McBride, J.T.; McBride, M.C. and Viles, P.H.: Hypoglycemia associated with propranolol. Pediatrics 51: 1085–1087 (1973).

    PubMed  CAS  Google Scholar 

  • McMurtry, R.J.: Propranolol, hypoglycemia and hypertensive crisis. Annals of Internal Medicine 80: 669–670 (1974).

    PubMed  CAS  Google Scholar 

  • Medical Letter: Effects of drugs in thyroid function tests. Medical Letter 23: 30–32 (1981).

    Google Scholar 

  • Melander, A.; Ranklev, E.; Sundler, F. and Westgren, U.: Beta2-adrenergic stimulation of thyroid hormone secretion. Endocrinology 97: 332–336 (1975).

    PubMed  CAS  Google Scholar 

  • Metz, S.A.; Halter, J.B. and Robertson, R.P.: Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Diabetes 27: 554–562 (1978).

    PubMed  CAS  Google Scholar 

  • Meyers, M.G. and Hope-Gill, H.F.: Effect of d- and dl-propranolol on glucose-stimulated insulin release. Clinical Pharmacology and Therapeutics 25: 303–308 (1979).

    Google Scholar 

  • Miller, R.A.: Propranolol and impotence. Annals of Internal Medicine 85: 682–683 (1976).

    PubMed  CAS  Google Scholar 

  • Miller, R.E.: Pancreatic neuroendocrinology: Peripheral neural mechanisms in regulation of the islets of Langerhans. Endocrinology Reviews 2: 471–494 (1981).

    CAS  Google Scholar 

  • Murphy, M.B.; Lewis, P.J.; Kuchner, E.; Schumer, B. and Dollery, C.T.: Glucose intolerance in hypertensive patients treated with diuretics: A fourteen year follow-up. Lancet 2: 1293–1295 (1982).

    PubMed  CAS  Google Scholar 

  • Newman, R.J. and Salerno, H.R.: Sexual dysfunction due to methyldopa. British Medical Journal 4: 106 (1974).

    PubMed  CAS  Google Scholar 

  • Nourok, D.S.; Glassock, R.S.; Solomon, D.M. and Maxwell, M.H.: Hypothyroidism following prolonged sodium nitroprusside therapy. American Journal of the Medical Sciences 248: 129–138 (1964).

    PubMed  CAS  Google Scholar 

  • Okun, R.; Russell, R.P. and Wilson, W.R.: Use of diazoxide with trichlormethiazide for hypertension. Archives of Internal Medicine 112: 862–868 (1963).

    Google Scholar 

  • Okun, R.; Wilson, W.R. and Gelfand, M.D.: Hyperglycemic effect of hypertension drugs. Journal of Chronic Diseases 17: 31–39 (1964).

    PubMed  CAS  Google Scholar 

  • Parker, M. and Atkinsen, J.: Withdrawal syndromes following cessation of treatment with antihypertensive drugs. General Pharmacology 13: 79–85 (1982).

    PubMed  CAS  Google Scholar 

  • Perrild, H.; Hansen, J.M.; Skorsted, L. and Christensen, L.K.: Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism. Clinical Endocrinology 18: 139–142 (1983).

    PubMed  CAS  Google Scholar 

  • Perry, H.M.: Treatment of mild hypertension. Preliminary results of a two year feasibility trend. Circulation Research 40 (Suppl.): 180 (1977).

    Google Scholar 

  • Pettinger, W.A.: Clonidine, a new antihypertensive drug. New England Journal of Medicine 293: 1179–1180 (1975).

    PubMed  CAS  Google Scholar 

  • Pita, J.C.; Lippman, M.E.; Thompson, E.B. and Loriaux, D.L.: Interaction of spironolactone and digitalis with the sex-dihydrotestosterone (DHT) receptor of rat ventral prostate. Endocrinology 97: 1521–1527 (1975).

    PubMed  CAS  Google Scholar 

  • Podolsky, S. and Pattavina, C.G.: Hyperosmolar nonketotic diabetic coma: A complication of propranolol therapy. Metabolism 22: 685–693 (1973).

    PubMed  CAS  Google Scholar 

  • Popp, D.A.; Shan, S.D. and Cryer, P.E.: Role of epinephrine mediated β-adrenergic mechanisms in hypoglycemia glucose counterregulation and posthypoglycemia hyperglycemia in insulin dependent diabetes mellitus. Journal of Clinical Investigation 69: 315–326 (1982).

    PubMed  CAS  Google Scholar 

  • Porter, R.H.; Cox, B.G.; Heaney, D.; Hostetter, T.H.; Stinebaugh, B.J. and Suki, W.N.: Treatment of hypoparathyroid patients with chlorthalidone. New England Journal of Medicine 298: 577–581 (1978).

    PubMed  CAS  Google Scholar 

  • Rassu, S.; Masala, A.; Alagna, S.; Ravasio, P.P. and Langer, M.: Acute effect of atenolol on serum thyroid hormones in hyperthyroid patients. Journal of Endocrinological Investigation 5: 39–41 (1982).

    PubMed  CAS  Google Scholar 

  • Reid, J.L.; Wing, L.M.H.; Dargie, H.J.; Hamilton, C.A.; Davies, D.S. and Dollery, C.T.: Clonidine withdrawal in hypertension. Lancet 1: 1171–1174 (1977).

    PubMed  CAS  Google Scholar 

  • Rifka, S.M.; Pita, J.C; Vigersky, R.A.; Wilson, Y.A. and Loriaux, D.L.: Interaction of digitalis and spironolactone with human sex steroid receptors. Journal of Clinical Endocrinology and Metabolism 46: 338–344 (1977).

    Google Scholar 

  • Robertson, R.P.; Halter, J.B. and Porte, D.: A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. Journal of Clinical Investigation 57: 791–795 (1976).

    PubMed  CAS  Google Scholar 

  • Robertson, R.P. and Porte, D.: The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. Journal of Clinical Investigation 52: 870–876 (1973a).

    PubMed  CAS  Google Scholar 

  • Robertson, R.P. and Porte, D.: Adrenergic modulation of basal insulin secretion in man. Diabetes 22: 1–8 (1973b).

    PubMed  CAS  Google Scholar 

  • Rowe, J.W.; Tobin, J.D.; Rosa, R.M. and Andres, R.: Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 29: 498–502 (1980).

    PubMed  CAS  Google Scholar 

  • Saibene, V.; Martinelli, G.; Vasconi, F. and Pozza, G.: Clonidine effect on insulin secretion and lipolysis in man. Acta Diabetologica Latina 15: 192–197 (1978).

    PubMed  CAS  Google Scholar 

  • Samii, K.; Ciancioni, C.H.; Rottembourg, J.; Bisseliches, F. and Jacobs, C.: Severe hypoglycaemia due to beta-blocking drugs in haemodialysis patients. Lancet 1: 545–546 (1976).

    PubMed  CAS  Google Scholar 

  • Schein, P.S.; Delellio, R.A.; Kahn, C.R.; Gorden, P. and Kraft, A.R.: Islet cell tumors: Current concepts and management. Annals of Internal Medicine 79: 239–257 (1973).

    PubMed  CAS  Google Scholar 

  • Shanks, R.G.; Lowe, D.C.; Hadden, D.R.; McDevett, D.G. and Montgomery, D.A.D.: Controlled trial of propranolol in thyrotoxicosis. Lancet 1: 993–994 (1969).

    PubMed  CAS  Google Scholar 

  • Shasha, S.M.; Shiller, M.; Aryeh, H.B. and Berheim, J.: Effect of pindolol on blood parathyroid hormone concentration. Israel Journal of Medical Sciences 17: 1189–1190 (1981).

    PubMed  CAS  Google Scholar 

  • Sirek, O.V.; Sirek, A. and Policora, Z.: Inhibition of sulphonylurea-stimulated insulin secretion by beta-adrenergic blockade. Diabetologia 11: 269–272 (1975).

    PubMed  CAS  Google Scholar 

  • State, R.M.; Smith, L.H.; Wilson, D.M.; Dube, W.J.; Goldsmith, R.J. and Arnaud, C.D.: Hydrochlorothiazide effects on serum calcium and immunoreactive parathyroid hormone concentrations. Annals of Internal Medicine 77: 587–591 (1972).

    Google Scholar 

  • Steiner, J.; Casser, J.; Mashiter, K.; Dawes, I.; Fraser, T.R. and Breckenridge, A.: Effects of methyldopa on prolactin and growth hormone. British Medical Journal 1: 1186–1188 (1976).

    PubMed  CAS  Google Scholar 

  • Stessman, J. and Ben-Ishay, D.: Chlorthalidone-induced impotence. British Medical Journal 281: 714 (1980).

    PubMed  CAS  Google Scholar 

  • Tuck, M.L.; Sowers, J.R.; Fittingoff, D.B.; Fisher, J.S.; Berg, G.J.; Asp, N.D. and Mayes, D.M.: Plasma corticosteroid concentrations during spironolactone administration: Evidence for adrenal biosynthetic blockade in man. Journal of Clinical Endocrinology and Metabolism 52: 1057–1061 (1981).

    PubMed  CAS  Google Scholar 

  • Turkington, R.W.: Prolactin secretion in patients treated with various drugs. Arch. Int. Med. 130: 349–354 (1972).

    CAS  Google Scholar 

  • Turner, P.: β-Adrenergic receptor blocking drugs in hyperthyroidism. Drugs 7: 48–54 (1974).

    PubMed  CAS  Google Scholar 

  • Updike, S.J. and Harrington, A.R.: Acute diabetic ketoacidosis — a complication of intravenous diazoxide treatment for refractory hypertension. New England Journal of Medicine 280: 768 (1969).

    PubMed  CAS  Google Scholar 

  • Velasco, M.; Silva, H.; Murillo, J.; Pellicer, R.; Urbina-Quintam, A. and Hernandez-Pieretti, O.: Effect of prazosin on blood lipids and on thyroid function in hypertensive patients. Journal of Cardiovascular Pharmacology 4 (Suppl.): S225–S227 (1982).

    PubMed  Google Scholar 

  • Waal-Manning, H.J.: Can β-blockers be used in diabetic patients? Drugs 17: 157–160 (1979).

    PubMed  CAS  Google Scholar 

  • Wartofsky, L.; Dimond, R.C.; Noel, G.L.; Frantz, A.G. and Earll, J.M.: Failure of propranolol to alter thyroid iodine release, thyroxine turnover on the TSH and PRL responses to thyrotropin-releasing hormone in patients with thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism 41: 485–490 (1975).

    PubMed  CAS  Google Scholar 

  • Wartofsky, L. and Burman, K.D.: Alterations in thyroid function in patients with systemic illness: The “euthyroid sick syndrome”. Endocrine Reviews 3: 164–217 (1982).

    PubMed  CAS  Google Scholar 

  • Webster, W.B. and McConnaughey, M.M.: Clonidine and glucose intolerance. Drug Intell. Clin. Pharm. 16: 325–328 (1982).

    PubMed  Google Scholar 

  • Weiler, J.M. and Borondy, P.E.: Effects of benzothiadiazine drugs on carbohydrate metabolism. Metabolism 14: 708–714 (1965).

    Google Scholar 

  • Wilkens, R.W.: New drugs for the treatment of hypertension. Annals of Internal Medicine 50: 1–10 (1959).

    Google Scholar 

  • Wolf, F.W.; Parmley, W.W., White, K. and Okun, R.: Drug-induced diabetes. Journal of the American Medical Association 185: 568–574 (1963).

    Google Scholar 

  • Woods, K.L.; Wright, A.D.; Kendall, M.J. and Block, E.: Lack of effect of propranolol and metoprolol on glucose tolerance in maturity-onset diabetics. Brit. Med, J. 281: 1321 (1980).

    CAS  Google Scholar 

  • Wray, R. and Sutcliffe, S.B.J.: Propranolol-induced hypoglycaemia and myocardial infarction. Brit. Med, J. 2: 592 (1972).

    CAS  Google Scholar 

  • Wright, A.D.; Barber, S.G.; Kendall, M.J. and Poole, P.H.: Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. British Medical Journal 1: 159–161 (1979).

    PubMed  CAS  Google Scholar 

  • Zanoboni, A.; Zanoboni-Muciaccia, W.; Zanussi, C. and Beraldi, R.: Suppression of clonidine-induced release of growth hormone by thyrotropin releasing hormone in humans. Journal of Endocrinological Investigation 2: 347–348 (1979).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Pharmacology, Division of Clinical Pharmacology, University of Colorado Health Sciences Center, Box C-237, 4200 East Ninth Avenue, Denver, CO, 80262, USA

    Eric P. Brass

Authors
  1. Eric P. Brass
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brass, E.P. Effects of Antihypertensive Drugs on Endocrine Function. Drugs 27, 447–458 (1984). https://doi.org/10.2165/00003495-198427050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198427050-00004

Keywords

Search

Navigation